Dr. Nick Terrafranca explains in detail the many facets involved in the commercialization process of a given therapy. Dr Terrafranca is the CEO of NeuroRecovery Technologies, the start-up working with Prof Reggie Edgerton to commercialise Prof Edgerton’s spinal neurostimulation breakthrough.
Dr Terrafranca of NeuroRecovery Technologies discusses commercialisation of treatments - SpinalCure Australia
Funding research to cure spinal cord injury